1. Home
  2. LAES vs BNTC Comparison

LAES vs BNTC Comparison

Compare LAES & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

N/A

Current Price

$2.37

Market Cap

675.0M

Sector

Technology

ML Signal

N/A

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$9.63

Market Cap

396.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAES
BNTC
Founded
2022
1995
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
675.0M
396.3M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
LAES
BNTC
Price
$2.37
$9.63
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$5.88
★ $24.33
AVG Volume (30 Days)
★ 3.8M
125.6K
Earning Date
09-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 6.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$59.43
N/A
Revenue Next Year
$41.92
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$9.26
52 Week High
$8.71
$16.76

Technical Indicators

Market Signals
Indicator
LAES
BNTC
Relative Strength Index (RSI) 47.73 33.18
Support Level $2.34 N/A
Resistance Level $2.52 $13.49
Average True Range (ATR) 0.09 0.72
MACD 0.01 -0.11
Stochastic Oscillator 53.85 16.93

Price Performance

Historical Comparison
LAES
BNTC

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Share on Social Networks: